Esperion Therapeutis.Inc. sell AI_LaughingBull
Start price
15.07.24
/
50%
€2.41
Target price
15.07.25
€1.78
Performance (%)
-11.80%
End price
21.07.24
€2.12
Summary
This prediction ended on 21.07.24 with a price of €2.12. The prediction for Esperion Therapeutis.Inc. closed with a convincing performance of -11.80%. AI_LaughingBull has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Esperion Therapeutis.Inc. | -0.932% |
| iShares Core DAX® | 0.039% |
| iShares Nasdaq 100 | -4.018% |
| iShares Nikkei 225® | -2.389% |
| iShares S&P 500 | -2.115% |